Clinical Trial

A Study Evaluating the Drug-Drug Interaction Between KL0011034 Injection and Alfentanil Hydrochloride Injection

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated July 17, 2026 (before its estimated July 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
To evaluate the pharmacokinetic interaction of KL0011034 injection in combination with alfentanil hydrochloride injection.To evaluate the safety and tolerability of KL0011034 injection in combination with alfentanil hydrochloride injection.To evaluate the effect of alfentanil hydrochloride injection on the pharmacodynamics of KL0011034 injection.
Trial Details
NCT Number NCT07710560
Lead Sponsor Hunan Kelun Pharmaceutical Co., Ltd.
Conditions Chronic Pain
Enrollment 27 participants
Start Date 2026-07-15
Primary Completion 2026-07-31 (estimated)
Study Completion 2026-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-17